Does OBINUTUZUMAB Cause Anaemia? 640 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 640 reports of Anaemia have been filed in association with OBINUTUZUMAB (Gazyva). This represents 4.5% of all adverse event reports for OBINUTUZUMAB.
640
Reports of Anaemia with OBINUTUZUMAB
4.5%
of all OBINUTUZUMAB reports
53
Deaths
111
Hospitalizations
How Dangerous Is Anaemia From OBINUTUZUMAB?
Of the 640 reports, 53 (8.3%) resulted in death, 111 (17.3%) required hospitalization, and 17 (2.7%) were considered life-threatening.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 640 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Atrial fibrillation (548)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which OBINUTUZUMAB Alternatives Have Lower Anaemia Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE